Cargando…

A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy

Gene expression network in cancer cells is orchestrated by a small number of master regulator transcription factors (MRTFs), which play a prominent role in regulating cancer intrinsic hallmarks, such as sustaining proliferative signaling, evading growth suppressors, resisting cell death, etc. A new...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sinha, Uttam K., Lin, De-Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091883/ https://www.ncbi.nlm.nih.gov/pubmed/37064876 http://dx.doi.org/10.7150/thno.83486

Ejemplares similares

STAT3, a Master Regulator of Anti-Tumor Immune Response
por: Rébé, Cédric, et al.
Publicado: (2019)

WT1 as an immunotherapy target for thymic epithelial tumors: a novel method to activate anti-tumor immunity
por: Takahashi, Nobuyuki, et al.
Publicado: (2019)

PD-L1, a Master Regulator of Immunity 2.0
por: Kochan, Grazyna
Publicado: (2023)

A novel statistical approach for identification of the master regulator transcription factor
por: Sikdar, Sinjini, et al.
Publicado: (2017)

Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape
por: Wu, Qinghua, et al.
Publicado: (2022)

Novel Cancer Immunotherapies and Antitumor Immunity
por: Zhao, Lei, et al.
Publicado: (2019)

Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
por: Gong, Ruining, et al.
Publicado: (2021)

The role of p53 in anti-tumor immunity and response to immunotherapy
por: Carlsen, Lindsey, et al.
Publicado: (2023)

The Role of Master Regulators in the Metabolic/Transcriptional Coupling in Breast Carcinomas
por: Baca-López, Karol, et al.
Publicado: (2012)

CUX1—Transcriptional Master Regulator of Tumor Progression in Pancreatic Neuroendocrine Tumors
por: Krug, Sebastian, et al.
Publicado: (2020)

Master Transcription Regulators and Transcription Factors Regulate Immune-Associated Differences Between Patients of African and European Ancestry With Colorectal Cancer
por: Myer, Parvathi A., et al.
Publicado: (2022)

Neutrophils and anti-cancer immunity: a paradigm shift in cancer immunotherapy
por: Sturey, Rebecca, et al.
Publicado: (2017)

An epigenetic master regulator teams up to become an epioncogene
por: Qi, Jianfei, et al.
Publicado: (2017)

GSK3 as a Master Regulator of Cellular Processes
por: Lichtinghagen, Ralf, et al.
Publicado: (2023)

Immunotherapy for Solid Tumors
por: de Saint Basile, Hortense, et al.
Publicado: (2023)

IRF4 as an Oncogenic Master Transcription Factor
por: Wong, Regina Wan Ju, et al.
Publicado: (2022)

Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy
por: Gu, Xu, et al.
Publicado: (2023)

Epigenetic modulation of the tumor immune microenvironment by nanoinducers to potentiate cancer immunotherapy
por: Zhang, Ning, et al.
Publicado: (2022)

The Potential Role of circRNA in Tumor Immunity Regulation and Immunotherapy
por: Xu, Zihao, et al.
Publicado: (2018)

GATA transcription factors as tissue-specific master regulators for induced responses
por: Block, Dena Hs, et al.
Publicado: (2015)

The FOXC2 Transcription Factor: A Master Regulator of Chemoresistance in Cancer
por: Hargadon, Kristian M., et al.
Publicado: (2023)

Master control: transcriptional regulation of mammalian Myod
por: Wardle, Fiona C.
Publicado: (2019)

Necroptosis DAMPens anti-tumor immunity
por: Shibata, K, et al.
Publicado: (2016)

The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy
por: Liu, Yuxia, et al.
Publicado: (2020)

Regulation of Geldanamycin Biosynthesis by Cluster-Situated Transcription Factors and the Master Regulator PhoP
por: Martín, Juan F., et al.
Publicado: (2019)

Role of the tumor immune microenvironment in tumor immunotherapy
por: Zhou, Changsheng, et al.
Publicado: (2022)

Understanding the Role of the Master Regulator XYR1 in Trichoderma reesei by Global Transcriptional Analysis
por: dos Santos Castro, Lilian, et al.
Publicado: (2016)

Master Regulators Connectivity Map: A Transcription Factors-Centered Approach to Drug Repositioning
por: De Bastiani, Marco A., et al.
Publicado: (2018)

The Role of Metabolism in Tumor Immune Evasion: Novel Approaches to Improve Immunotherapy
por: Cruz-Bermúdez, Alberto, et al.
Publicado: (2021)

Superenhancers as master gene regulators and novel therapeutic targets in brain tumors
por: Zhuang, Hai-Hui, et al.
Publicado: (2023)

Interplay and cooperation between SREBF1 and master transcription factors regulate lipid metabolism and tumor-promoting pathways in squamous cancer
por: Li, Li-Yan, et al.
Publicado: (2021)

RUNX3 methylation and anti-tumor immunity
por: Menheniott, Trevelyan R., et al.
Publicado: (2015)

Mouse models to decipher anti-tumor immunity
por: Parigger, Thomas, et al.
Publicado: (2019)

The Master’s Tools Will Never Dismantle the Master’s House: The Role of Diversity in Anti-Racist Education
por: Lincoln, Karen
Publicado: (2021)

Targeting Innate Immune Cells for Immunotherapy
por: Carreño, Leandro J., et al.
Publicado: (2017)

Imprinted gene Zinc finger protein 127 is a novel regulator of master pluripotency transcription factor, Oct4
por: Kwon, Yoo-Wook, et al.
Publicado: (2018)

MAPKAPK2: the master regulator of RNA-binding proteins modulates transcript stability and tumor progression
por: Soni, Sourabh, et al.
Publicado: (2019)

Mechanism and effects of extramedullary hematopoiesis on anti-tumor immunity
por: Chen, Zefang, et al.
Publicado: (2023)

SIRT1 is a positive regulator of the master osteoblast transcription factor, RUNX2
por: Zainabadi, Kayvan, et al.
Publicado: (2017)

Master Regulator Activating Transcription Factor 3 (ATF3) in Metabolic Homeostasis and Cancer
por: Ku, Hui-Chen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q0q2vhvk0obveodcgk1c7anhuf